Baseline tumor genomic and gut microbiota association with clinical outcomes in newly diagnosed glioblastoma (GBM) treated with atezolizumab in combination with temozolomide (TMZ) and radiation.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shiao-Pei S. Weathers, Haifeng Zhu, Mark Knafl, Ashish Damania, Carlos Kamiya-Matsuoka, Rebecca A. Harrison, Larry Lyons, Cindy Yun, Walter C. Darbonne, Monica Loghin, Marta Penas-Prado, Nazanin Majd, W. K. Alfred Yung, Barbara Jane O'Brien, Ignacio Ivan Wistuba, Andrew Futreal, Jennifer Ann Wargo, Nadim J. Ajami, Scott Eric Woodman, John Frederick de Groot
Institutions: The University of Texas MD Anderson Cancer Center, Genentech
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Genentech
OpenAlex ID: W4286297255